G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/574 (2006.01)
Patent
CA 2650129
Disclosed is a method for determining survival and relapse of a patient undergoing therapy for a tumor by determining a residual cancer burden index based on the bidimensional diameters of a primary tumor bed of said tumor in a resection specimen, the proportion of the primary tumor bed area that contains invasive carcinoma, the number of regional lymph nodes containing metastatic carcinoma, the diameter of the largest metastasis in an regional lymph node; and the fractional reduction in lymph node size with each added positive lymph node.
L'invention concerne une méthode pour déterminer la survie et la rechute d'un patient sous thérapie pour une tumeur, en déterminant un indice de charge du cancer résiduel en fonction des diamètres bidimensionnels d'un lit tumoral primaire de ladite tumeur dans un spécimen de résection, de la proportion de la région du lit tumoral primaire qui contient le carcinome invasif, du nombre de ganglions lymphatiques régionaux qui contiennent le carcinome métastatique, du diamètre de la plus grosse métastase dans un ganglion lymphatique régional et de la réduction partielle de la taille des ganglions lymphatiques pour chaque ganglion lymphatique positif ajouté.
Hatzis Christos
Pusztai Lajos
Symmans Fraser W.
Board Of Regents The University Of Texas System
Nuvera Biosciences Inc.
Ridout & Maybee Llp
LandOfFree
Method of measuring residual cancer and predicting patient... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of measuring residual cancer and predicting patient..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of measuring residual cancer and predicting patient... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1376101